1. Home
  2. ILMN vs TOST Comparison

ILMN vs TOST Comparison

Compare ILMN & TOST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • TOST
  • Stock Information
  • Founded
  • ILMN 1998
  • TOST 2012
  • Country
  • ILMN United States
  • TOST United States
  • Employees
  • ILMN N/A
  • TOST N/A
  • Industry
  • ILMN Medical Specialities
  • TOST EDP Services
  • Sector
  • ILMN Health Care
  • TOST Technology
  • Exchange
  • ILMN Nasdaq
  • TOST Nasdaq
  • Market Cap
  • ILMN 23.6B
  • TOST 22.0B
  • IPO Year
  • ILMN 2000
  • TOST 2021
  • Fundamental
  • Price
  • ILMN $136.67
  • TOST $37.86
  • Analyst Decision
  • ILMN Buy
  • TOST Buy
  • Analyst Count
  • ILMN 17
  • TOST 22
  • Target Price
  • ILMN $162.76
  • TOST $35.27
  • AVG Volume (30 Days)
  • ILMN 2.1M
  • TOST 4.7M
  • Earning Date
  • ILMN 02-06-2025
  • TOST 02-13-2025
  • Dividend Yield
  • ILMN N/A
  • TOST N/A
  • EPS Growth
  • ILMN N/A
  • TOST N/A
  • EPS
  • ILMN N/A
  • TOST N/A
  • Revenue
  • ILMN $4,390,000,000.00
  • TOST $4,658,000,000.00
  • Revenue This Year
  • ILMN N/A
  • TOST $30.06
  • Revenue Next Year
  • ILMN $4.08
  • TOST $23.55
  • P/E Ratio
  • ILMN N/A
  • TOST N/A
  • Revenue Growth
  • ILMN N/A
  • TOST 29.50
  • 52 Week Low
  • ILMN $97.36
  • TOST $16.13
  • 52 Week High
  • ILMN $156.66
  • TOST $44.12
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 47.37
  • TOST 52.76
  • Support Level
  • ILMN $131.75
  • TOST $36.23
  • Resistance Level
  • ILMN $153.06
  • TOST $38.68
  • Average True Range (ATR)
  • ILMN 5.42
  • TOST 1.23
  • MACD
  • ILMN 0.29
  • TOST 0.02
  • Stochastic Oscillator
  • ILMN 28.30
  • TOST 73.07

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About TOST Toast Inc.

Toast is a us-based restaurant technology company that provides point-of-sale, payment processing, and various software services to 127,000 restaurant locations across the United States as of September 2024. The firm generates sales from software subscription fees, as a percentage take rate from each financial transaction it processes, from loan origination and servicing fees from its Toast Capital arm, and from hardware installation and professional services. Unlike competitors, Toast intermediates every payment transaction on its platform, processing some $126 billion in gross platform volume in 2023. The firm's product offerings span point-of-sale systems, inventory and payroll management, delivery integration, e-commerce ordering, reservation management, and loyalty programs.

Share on Social Networks: